Comparative Genomics and Proteomics in Drug Discovery (häftad)
Format
Häftad (Paperback / softback)
Språk
Engelska
Antal sidor
164
Utgivningsdatum
2019-09-05
Förlag
CRC Press
Medarbetare
Coward, Kevin
Illustrationer
Black & white illustrations
Dimensioner
231 x 155 x 13 mm
Vikt
272 g
Antal komponenter
1
Komponenter
49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam
ISBN
9780367389734

Comparative Genomics and Proteomics in Drug Discovery

Vol 58

Häftad,  Engelska, 2019-09-05
1166
  • Skickas från oss inom 7-10 vardagar.
  • Fri frakt över 249 kr för privatkunder i Sverige.
Finns även som
Visa alla 3 format & utgåvor
Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.
Visa hela texten

Passar bra ihop

  1. Comparative Genomics and Proteomics in Drug Discovery
  2. +
  3. Co-Intelligence

De som köpt den här boken har ofta också köpt Co-Intelligence av Ethan Mollick (häftad).

Köp båda 2 för 1394 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Fler böcker av författarna

Övrig information

John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.

Innehållsförteckning

1. Comparative Genomics and Drug Discovery in Trypanosomatids 2. The Practical Implications of Comparative Kinetoplastid Genomics 3. The Relevance of Host Genes in Malaria 4. Nicotinic Acetylcholine Receptors as Drug/Chemical Targets, Contributions from Comparative Genomics, Forward and Reverse Genetics 5. Discovery of Novel Sodium Channel Inhibitors - A Gene Family-Based Approach 6. 'Omics' in Translational Medicine : Are They Lost in Translation? 7. Drug-Target Discovery In Silico : Using the Web to Identify Novel Molecular Targets for Drug Action